 | Up a level |
Busnadiego, Idoia; Abela, Irene A; Frey, Pascal M; Hofmaenner, Daniel A; Scheier, Thomas C; Schuepbach, Reto A; Buehler, Philipp K; Brugger, Silvio D; Hale, Benjamin G (2022). Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease. PLoS biology, 20(7), e3001709. Public Library of Science 10.1371/journal.pbio.3001709
